Journal of New Drugs is categorized under in Oak Park, IL and active since 2007.
Journal of New Drugs was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Duncan Hutcheon, Owner at the company’s single location by writing to 106 South Ridgeland Avenue, Oak Park, Illinois IL 60302 or by phoning (708) 358-4000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Journal of New Drugs |
| Contact Person: | Duncan Hutcheon, Owner |
| Address: | 106 South Ridgeland Avenue, Oak Park, Illinois 60302 |
| Phone Number: | (708) 358-4000 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
Journal of New Drugs was started in 2007 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Duncan Hutcheon, Owner for inquiries that concern Journal of New Drugs by calling the company number (708) 358-4000, as your correspondence is most welcome. Additionally, the physical location of the single location of Journal of New Drugs can be found at the coordinates 41.886709,-87.78457 as well as the street address 106 South Ridgeland Avenue in Oak Park, Illinois 60302.
For its online presence, you may visit Journal of New Drugs’s website at and engage with its social media outlets through on Twitter and on Facebook.